Comment
doi: 10.1128/JCM.00504-13.
Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays
- PMID: 23682102
- PMCID: PMC3716045
- DOI: 10.1128/JCM.00504-13
Item in Clipboard
Comment
Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays
J Clin Microbiol.
2013 Jun.
No abstract available
Comment in
-
Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays".J Clin Microbiol. 2013 Jun;51(6):2014. doi: 10.1128/JCM.00545-13. J Clin Microbiol. 2013. PMID: 23682103 Free PMC article. No abstract available.
Comment on
-
Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.J Clin Microbiol. 2013 Apr;51(4):1244-6. doi: 10.1128/JCM.03234-12. Epub 2013 Jan 16. J Clin Microbiol. 2013. PMID: 23325820 Free PMC article.
Similar articles
-
Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays".J Clin Microbiol. 2013 Jun;51(6):2014. doi: 10.1128/JCM.00545-13. J Clin Microbiol. 2013. PMID: 23682103 Free PMC article. No abstract available.
-
Evaluation of Epstein-Barr virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays.J Clin Microbiol. 2013 Apr;51(4):1244-6. doi: 10.1128/JCM.03234-12. Epub 2013 Jan 16. J Clin Microbiol. 2013. PMID: 23325820 Free PMC article.
-
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.Antiviral Res. 2003 Apr;58(2):149-57. doi: 10.1016/s0166-3542(02)00210-3. Antiviral Res. 2003. PMID: 12742575
-
Human herpesvirus 8: an update.Microbes Infect. 2004 Mar;6(3):328-35. doi: 10.1016/j.micinf.2003.11.013. Microbes Infect. 2004. PMID: 15065569 Review.
-
Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system.Herpes. 2004 Jun;11 Suppl 2:120A-127A. Herpes. 2004. PMID: 15319099 Review.
Cited by
-
Reply to "Calibration technologies for correct determination of Epstein-Barr Virus, human herpesvirus 6 (HHV-6), and HHV-8 antiviral drug susceptibilities by use of real-time-PCR-based assays".J Clin Microbiol. 2013 Jun;51(6):2014. doi: 10.1128/JCM.00545-13. J Clin Microbiol. 2013. PMID: 23682103 Free PMC article. No abstract available.
References
-
- Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. 2001. Biology of Kaposi's sarcoma. Eur. J. Cancer 37:1251–1269 - PubMed
-
- Macsween KF, Crawford DH. 2003. Epstein-Barr virus—recent advances. Lancet Infect. Dis. 3:131–140 - PubMed
-
- Zerr DM. 2006. Human herpesvirus 6: a clinical update. Herpes 13:20–24 - PubMed
-
- Ballout M, Germi R, Fafi-Kremer S, Guimet J, Bargues G, Seigneurin JM, Morand P. 2007. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression. J. Virol. Methods 143:38–44 - PubMed
-
- Isegawa Y, Takemoto M, Yamanishi K, Ohshima A, Sugimoto N. 2007. Real time PCR determination of human herpesvirus 6 antiviral drug susceptibility. J. Virol. Methods 140:25–31 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
